These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7599574)

  • 21. Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients.
    Tollemar J; Gross N; Dolgiras N; Jarstrand C; Ringdén O; Hammarström L
    Bone Marrow Transplant; 1999 Feb; 23(3):283-90. PubMed ID: 10084261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study.
    Narvios AB; Lichtiger B
    Haematologica; 2001 Jul; 86(7):749-52. PubMed ID: 11454531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT.
    Klumpp TR; Herman JH; Schnell MK; Goldberg SL; Mangan KF
    Bone Marrow Transplant; 1996 Sep; 18(3):559-64. PubMed ID: 8879617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early bacterial infections after allogenic bone marrow grafts].
    Guyotat D; Plotton C; Archimbaud E; Fiere D; Fleurette J
    Pathol Biol (Paris); 1988 Sep; 36(7):896-8. PubMed ID: 3059272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
    Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
    Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qualitative detection of human cytomegalovirus DNA in the plasma of bone marrow transplant recipients: value as a predictor of disease progression.
    Behzad-Behbahani A; Ehsanipour F; Alborzi A; Nourani H; Ramzi M; Rasoli M
    Exp Clin Transplant; 2004 Jun; 2(1):196-200. PubMed ID: 15859928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
    Noskin G; Pietrelli L; Gurwith M; Bowden R
    Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early bacterial infections in 103 patients treated with bone marrow transplantation].
    Tomás JF; Hernández LM; Peñarrubia MJ; Figuera A; Jiménez ML; Cámara R; Arranz R; López JL; Cruz J; Fernández-Rañada JM
    Sangre (Barc); 1994 Jun; 39(3):191-6. PubMed ID: 7940049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fungal colonization and infection in Boston keratoprosthesis.
    Barnes SD; Dohlman CH; Durand ML
    Cornea; 2007 Jan; 26(1):9-15. PubMed ID: 17198007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early infections in adults undergoing matched related and matched unrelated/mismatched donor stem cell transplantation: a comparison of incidence.
    van Kraaij MG; Verdonck LF; Rozenberg-Arska M; Dekker AW
    Bone Marrow Transplant; 2002 Sep; 30(5):303-9. PubMed ID: 12209352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial morbidity in bone marrow transplant recipients: a prospective study.
    Leigh S; Wilson KC; Burns R; Clark RE
    Bone Marrow Transplant; 1995 Nov; 16(5):635-40. PubMed ID: 8547859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants.
    Aksu G; Ruhi MZ; Akan H; Bengisun S; Ustün C; Arslan O; Ozenci H
    Bone Marrow Transplant; 2001 Jan; 27(2):201-5. PubMed ID: 11281391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients.
    Schmeiser T; Kern WV; Hay B; Hertenstein B; Arnold R
    Bone Marrow Transplant; 1993 Jul; 12(1):57-63. PubMed ID: 8374536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of plasma polymerase chain reaction for human herpes virus-6 among pediatric bone marrow transplant recipients: results of a pilot study.
    Allen UD; Tellier R; Doyle J; Petric M; Wasfy S; Kumar P; Calderwood S; Freedman M; Saunders F
    Bone Marrow Transplant; 2001 Sep; 28(5):473-7. PubMed ID: 11593320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of surveillance cultures in neutropenic patients receiving selective intestinal decontamination.
    de Jong PJ; de Jong MD; Kuijper EJ; van der Lelie H
    Scand J Infect Dis; 1993; 25(1):107-13. PubMed ID: 8460334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.